Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Rallybio Corporation (RLYB)

  • Technical Exchange News
  • March 03, 2025, 18:50 UTC
  • 16

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Outset Medical Inc. (OM)

  • Technical Exchange News
  • March 03, 2025, 18:50 UTC
  • 16

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Generation Bio (GBIO)

  • Technical Exchange News
  • March 03, 2025, 18:49 UTC
  • 16

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

CytomX Therapeutics Inc (CTMX)

  • Technical Exchange News
  • March 03, 2025, 18:49 UTC
  • 17

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Acurx Pharmaceuticals Inc. (ACXP)

  • Technical Exchange News
  • March 03, 2025, 18:49 UTC
  • 17

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Beverly JCG Ltd. (VFP)

  • Technical Exchange News
  • March 03, 2025, 15:38 UTC
  • 28

SGX symbol attribute type Security_Name was changed. Previous value: -. New value: Beverly JCG.

Comment Full text

Health Medical Corporation Limited (5NG)

  • Technical Exchange News
  • March 03, 2025, 15:38 UTC
  • 27

SGX symbol attribute type Security_Name was changed. Previous value: -. New value: Healthway Med.

Comment Full text

Fresh Tracks Therapeutics, Inc. (FRTX)

  • Technical Exchange News
  • March 03, 2025, 10:23 UTC
  • 14

Grey symbol attribute type Security_Name was changed. Previous value: HAWTHORN RES CORP. New value: FRESH TRACKS THERAPEUTICS.

Comment Full text

Curis Inc (CRIS)

  • Technical Exchange News
  • March 01, 2025, 05:21 UTC
  • 23

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Atossa Therapeutics Inc. (ATOS)

  • Technical Exchange News
  • March 01, 2025, 05:21 UTC
  • 21

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text
  • Previous
  • 97
  • 98
  • 99
  • 100
  • 101
  • Next

Search

News categories

  • Technical Exchange News(9375)
  • Event(407)
  • SEC News(153222)
  • FDA Approval(8741)
  • Company Report(721)
  • Business News(104513)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin